Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 724670, 9 pages
http://dx.doi.org/10.1155/2014/724670
Research Article

Lycopene Inhibits Urotensin-II-Induced Cardiomyocyte Hypertrophy in Neonatal Rat Cardiomyocytes

1Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111, Taiwan
2Department of Surgery, School of Medicine, Taipei Medical University, Taipei 110, Taiwan
3Department of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung 40402, Taiwan
4Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
5Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan
6Division of Cardiology, Department of Internal Medicine and Graduate Institute of Clinical Medical Science, China Medical University, Taichung 40402, Taiwan
7Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan
8Department of Biochemistry, School of Medicine, China Medical University, Taichung 40402, Taiwan

Received 3 March 2014; Accepted 24 April 2014; Published 25 May 2014

Academic Editor: Wei-Wen Kuo

Copyright © 2014 Hung-Hsing Chao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Swynghedauw, “Remodeling of the heart in chronic pressure overload,” Basic Research in Cardiology, vol. 86, pp. 99–105, 1991. View at Google Scholar · View at Scopus
  2. Y. Wang, “Signal transduction in cardiac hypertrophy—dissecting compensatory versus pathological pathways utilizing a transgenic approach,” Current Opinion in Pharmacology, vol. 1, no. 2, pp. 134–140, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. Ames, H. M. Sarau, J. K. Chambers et al., “Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14,” Nature, vol. 401, no. 6750, p. 282, 1999. View at Google Scholar · View at Scopus
  4. B. Ross, K. McKendy, and A. Giaid, “Role of urotensin II in health and disease,” American Journal of Physiology, Regulatory Integrative and Comparative Physiology, vol. 298, no. 5, pp. R1156–R1172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-C. Liu, C.-H. Chen, J.-J. Chen, and T.-H. Cheng, “Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor,” Molecular Pharmacology, vol. 76, no. 6, pp. 1186–1195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Djordjevic, R. S. BelAiba, S. Bonello, J. Pfeilschifter, J. Hess, and A. Görlach, “Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 3, pp. 519–525, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-M. Li, N. P. Gall, D. J. Grieve, M. Chen, and A. M. Shah, “Activation of NADPH oxidase during progression of cardiac hypertrophy to failure,” Hypertension, vol. 40, no. 4, pp. 477–484, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Gruson, A. Ginion, N. Decroly et al., “Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3β signaling pathway,” Peptides, vol. 31, no. 7, pp. 1326–1333, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Kerkelä, K. Woulfe, and T. Force, “Glycogen synthase kinase-3β-actively inhibiting hypertrophy,” Trends in Cardiovascular Medicine, vol. 17, no. 3, pp. 91–96, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Y. Oudit, H. Sun, B.-G. Kerfant, M. A. Crackower, J. M. Penninger, and P. H. Backx, “The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease,” Journal of Molecular and Cellular Cardiology, vol. 37, no. 2, pp. 449–471, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. N. R. Leslie, D. Bennett, Y. E. Lindsay, H. Stewart, A. Gray, and C. P. Downes, “Redox regulation of PI 3-kinase signalling via inactivation of PTEN,” EMBO Journal, vol. 22, no. 20, pp. 5501–5510, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Blum, M. Monir, I. Wirsansky, and S. Ben-Arzi, “The beneficial effects of tomatoes,” European Journal of Internal Medicine, vol. 16, no. 6, pp. 402–404, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Mordente, B. Guantario, E. Meucci et al., “Lycopene and cardiovascular diseases: an update,” Current Medicinal Chemistry, vol. 18, no. 8, pp. 1146–1163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Fuentes, R. Carle, L. Astudillo et al., “Antioxidant and antiplatelet activities in extracts from green and fully ripe tomato fruits (Solanum lycopersicum) and pomace from industrial tomato processing,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 867578, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Trejo-Solis, J. Pedraza-Chaverri, M. Torres-Ramos et al., “Multiple molecular and cellular mechanisms of action of lycopene in cancer inhibition,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 705121, 17 pages, 2013. View at Publisher · View at Google Scholar
  16. T. Rissanen, S. Voutilainen, K. Nyyssönen, and J. T. Salonen, “Lycopene, atherosclerosis, and coronary heart disease,” Experimental Biology and Medicine, vol. 227, no. 10, pp. 900–907, 2002. View at Google Scholar · View at Scopus
  17. T.-H. Cheng, N.-L. Shih, C.-H. Chen et al., “Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced β-myosin heavy chain gene expression and cardiomyocyte hypertrophy,” Journal of Biomedical Science, vol. 12, no. 1, pp. 123–133, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. Y.-H. Hsu, Y.-C. Chen, T.-H. Chen et al., “Far-infrared therapy induces the nuclear translocation of PLZF which inhibits VEGF-induced proliferation in human umbilical vein endothelial cells,” PLoS ONE, vol. 7, no. 1, Article ID e30674, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. E. Hardt and J. Sadoshima, “Glycogen synthase kinase-3β a novel regulator of cardiac hypertrophy and development,” Circulation Research, vol. 90, no. 10, pp. 1055–1063, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Kitagishi and S. Matsuda, “Redox regulation of tumor suppressor PTEN in cancer and aging (Review),” International Journal of Molecular Medicine, vol. 31, no. 3, pp. 511–515, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Gebremedhin, M. Terashvili, N. Wickramasekera et al., “Redox signaling via oxidative inactivation of PTEN modulates pressure-dependent myogenic tone in rat middle cerebral arteries,” PLoS ONE, vol. 8, no. 7, Article ID e68498, 2013. View at Publisher · View at Google Scholar
  22. G. Y. Oudit and J. M. Penninger, “Cardiac regulation by phosphoinositide 3-kinases and PTEN,” Cardiovascular Research, vol. 82, no. 2, pp. 250–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. M. Mohamadin, A. A. Elberry, A. D. Mariee, G. M. Morsy, and F. A. Al-Abbasi, “Lycopene attenuates oxidative stress and heart lysosomal damage in isoproterenol induced cardiotoxicity in rats: a biochemical study,” Pathophysiology, vol. 19, no. 2, pp. 121–130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Bohm, “Lycopene and heart health,” Molecular Nutrition & Food Research, vol. 56, no. 2, pp. 296–303, 2012. View at Publisher · View at Google Scholar
  25. H. Li, Z. Deng, R. Liu, S. Loewen, and R. Tsao, “Carotenoid compositions of coloured tomato cultivars and contribution to antioxidant activities and protection against H2O2-induced cell death in H9c2,” Food Chemistry, vol. 136, no. 2, pp. 878–888, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Palozza, N. Parrone, R. Simone, and A. Catalano, “Role of lycopene in the control of ROS-mediated cell growth: implications in cancer prevention,” Current Medicinal Chemistry, vol. 18, no. 12, pp. 1846–1860, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. R. E. Simone, M. Russo, A. Catalano et al., “Lycopene inhibits NF-KB-Mediated IL-8 expression and changes redox and PPARγ signalling in cigarette smoke-stimulated macrophages,” PLoS ONE, vol. 6, no. 5, Article ID e19652, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Palozza, R. Simone, A. Catalano et al., “Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages,” Journal of Nutritional Biochemistry, vol. 21, no. 1, pp. 34–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. P. H. Sugden and A. Clerk, “Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes,” Antioxidants and Redox Signaling, vol. 8, no. 11-12, pp. 2111–2124, 2006. View at Google Scholar · View at Scopus
  30. K. M. Rice, S. Uddemarri, D. H. Desai et al., “PGF2α-associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN,” Prostaglandins and Other Lipid Mediators, vol. 85, no. 1-2, pp. 49–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Planavila, R. Rodríguez-Calvo, X. Palomer et al., “Atorvastatin inhibits GSK-3β phosphorylation by cardiac hypertrophic stimuli,” Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids, vol. 1781, no. 1-2, pp. 26–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Crackower, G. Y. Oudit, I. Kozieradzki et al., “Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways,” Cell, vol. 110, no. 6, pp. 737–749, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Schwartzbauer and J. Robbins, “The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival,” The Journal of Biological Chemistry, vol. 276, no. 38, pp. 35786–35793, 2001. View at Publisher · View at Google Scholar · View at Scopus